Angioedema biomarker research study
Part of Cancer, Genetic & congenital, Heart & circulation, Immune system & allergy, Skin clinical trials.
This study collects blood samples (and optional skin samples) from people with angioedema to learn more about the condition and find better ways to diagnose and treat it. If you join, you may help scientists understand angioedema better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older.
- You have been diagnosed with angioedema by a doctor or through genetic testing.
- You are willing to have a blood sample taken, and optionally a small skin sample.
- You are not taking any medicines that would interfere with the study tests.
- You do not have a bleeding disorder like hemophilia that makes blood draws risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at IgE, a protein involved in allergic reactions, to better understand its role in different immune-related diseases. It aims to find out how different forms of IgE relate to health and disease, which may help improve diagnosis or treatment.
This registry study collects information from people with hereditary angioedema (swelling episodes) and related types, with or without a C1-related blood condition. It may help doctors better understand different patterns of swelling and improve future care.
This study is an extension trial of an oral medicine (PHA-022121) for treating acute attacks in people with hereditary angioedema (HAE), especially HAE type III (HAE-nC1INH). It checks whether continuing this oral treatment can safely help manage attacks after you’ve taken it before.
This is a study that follows people with an immune-related illness at Lille University Hospital to better understand their care needs over time. By collecting information regularly, the study may help improve how future patients are monitored and treated.
This study looks at the genes that cause hereditary angioedema (HAE), a condition with sudden swelling in the hands, feet, face, or airways. By joining, you help doctors understand the disease better, which could lead to better care for you and others.
This study checks if a blood test measuring C1-inhibitor function can help diagnose hereditary angioedema (HAE), a rare condition that causes painful swelling episodes. If you or a close family member have had swelling without rash or itching that lasts 1-5 days and doesn't get better with allergy meds, this trial may be for you.
Hear when a new Angioedema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.